Inflammation Improve Articles & Analysis
2 news found
Randomized, placebo-controlled, double-blind Phase II trial to treat 42 patients ongoing in four European countries with ESO-101 ESO-101, EsoCap’s lead product candidate, consists of a capsule with a rolled, thin mucoadhesive film, loaded with the anti-inflammatory corticosteroid, mometasone furoate In a previous trial, EsoCap’s proprietary and unique targeted application ...
The paper outlines the discovery of natural rice-based peptides clinically proven to impact inflammation and improve physical test results in an elderly population. ...